Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Tropical Medicine and Infectious Disease|July 26, 2024
One Health, One Future: A Unified Approach to a Balanced EcosystemSantanu Sasidharan, Claire J Standley
Journal of Biomolecular Structure & Dynamics|January 7, 2022
Discovery of compounds inhibiting SARS-COV-2 multi-targetsSantanu Sasidharan, Neellohit Sarkar, Prakash Saudagar
ACS Omega|December 6, 2021
Critical Insight into Plausible Acquired Tocopherol Pathway in Neglected Human TrypanosomatidsSantanu Sasidharan, Timir Tripathi, Prakash Saudagar
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 19, 2020
Computational design of a potential multi-epitope subunit vaccine using immunoinformatics to fight Ebola virusAjinkya Kadam, Santanu Sasidharan, Prakash Saudagar
International Journal of Biological Macromolecules|February 20, 2022
Biofunctionalized Chrysin-conjugated gold nanoparticles neutralize Leishmania parasites with high efficacyShweta Raj, Santanu Sasidharan, Timir Tripathi, et al.
Parasitology Research|June 7, 2020
An overview of biochemically characterized drug targets in metabolic pathways of Leishmania parasiteShweta Raj, Santanu Sasidharan, S N Balaji, et al.
Current Pharmaceutical Biotechnology|January 3, 2020
Green-Synthesized FeSO4 Nanoparticles Exhibit Antibacterial and Cytotoxic Activity by DNA DegradationB Bharath, Santanu Sasidharan, Sai K Bhamidipati, et al.
Plos One|August 20, 2019
Identification of lead molecules against potential drug target protein MAPK4 from L. donovani: An in-silico approach using docking, molecular dynamics and binding free energy calculationShweta Raj, Santanu Sasidharan, Vikash Kumar Dubey, et al.
Molecules (Basel, Switzerland)|March 26, 2022
Amyloid Cross-Seeding: Mechanism, Implication, and InhibitionSushma Subedi, Santanu Sasidharan, Niharika Nag, et al.
Scientific Reports|November 9, 2019
Biochemical characterization and chemical validation of Leishmania MAP Kinase-3 as a potential drug targetShweta Raj, Gundappa Saha, Santanu Sasidharan, et al.
Pageof 3